StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Needham & Company Upgrades ResMed (RMD) to Hold
January 23, 2018 7:34 AM
Needham & Company upgraded ResMed (NYSE: RMD) from Underperform to Hold.Analyst Mike Matson commented, "RMD's revenue and EPS both significantly ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Upgrades
Next Articles
ResMed (RMD) Gains Over 17% on FQ2 Earnings Beat, Ratings Upgrades and Price Target Boost
January 23, 2018 12:13 PM
Northland Capital Markets Upgrades ResMed (RMD) to Market Perform
January 23, 2018 8:50 AM
ResMed (RMD) PT Raised to $76 at Barclays
January 23, 2018 5:18 AM
ResMed (RMD) Tops Q2 EPS by 22c, Beats on Revenues
January 22, 2018 4:06 PM
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2018
January 22, 2018 4:05 PM
